Logo image of DWTX

DOGWOOD THERAPEUTICS INC (DWTX) Stock Price, Quote, News and Overview

NASDAQ:DWTX - Nasdaq - US92829J2033 - Common Stock - Currency: USD

4.82  +0.13 (+2.77%)

DWTX Quote, Performance and Key Statistics

DOGWOOD THERAPEUTICS INC

NASDAQ:DWTX (7/23/2025, 4:12:44 PM)

4.82

+0.13 (+2.77%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap9.21M
Shares1.91M
Float1.66M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-06 2025-08-06
IPO12-17 2020-12-17


DWTX short term performance overview.The bars show the price performance of DWTX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

DWTX long term performance overview.The bars show the price performance of DWTX in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of DWTX is 4.82 USD. In the past month the price decreased by -1.47%.

DOGWOOD THERAPEUTICS INC / DWTX Daily stock chart

DWTX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.55 336.59B
AMGN AMGEN INC 14.89 166.27B
GILD GILEAD SCIENCES INC 14.67 141.26B
VRTX VERTEX PHARMACEUTICALS INC N/A 122.48B
REGN REGENERON PHARMACEUTICALS 12.92 61.80B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 42.46B
ARGX ARGENX SE - ADR 100.07 35.13B
ONC BEONE MEDICINES LTD-ADR 7.54 31.91B
BNTX BIONTECH SE-ADR N/A 27.55B
SMMT SUMMIT THERAPEUTICS INC N/A 20.80B
INSM INSMED INC N/A 19.62B
BIIB BIOGEN INC 8.28 19.19B

About DWTX

Company Profile

DWTX logo image Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. The company is headquartered in Alpharetta, Georgia and currently employs 12 full-time employees. The company went IPO on 2020-12-17. The Company’s research pipeline includes two separate mechanistic platforms with a non-opioid analgesic program and an antiviral program. The proprietary, non-opioid, Nav 1.7 analgesic program is centered on its lead development candidate, Halneuron, which is a specific voltage-gated sodium channel modulator, a mechanism known to be effective for reducing pain transmission. In clinical studies, Halneuron treatment has demonstrated pain reduction in pain related to general cancer and in pain related to chronic chemotherapy-induced neuropathic pain (CINP). The Company’s antiviral program includes IMC-1 and IMC-2, which are fixed-dose combinations of nucleoside analog, anti-herpes antivirals and the anti-inflammatory agent celecoxib for the treatment of fibromyalgia (FM) and Long-COVID (LC).

Company Info

DOGWOOD THERAPEUTICS INC

44 Milton Avenue

Alpharetta GEORGIA US

Employees: 12

DWTX Company Website

DWTX Investor Relations

Phone: 18666208655

DOGWOOD THERAPEUTICS INC / DWTX FAQ

What is the stock price of DOGWOOD THERAPEUTICS INC today?

The current stock price of DWTX is 4.82 USD. The price increased by 2.77% in the last trading session.


What is the ticker symbol for DOGWOOD THERAPEUTICS INC stock?

The exchange symbol of DOGWOOD THERAPEUTICS INC is DWTX and it is listed on the Nasdaq exchange.


On which exchange is DWTX stock listed?

DWTX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for DOGWOOD THERAPEUTICS INC stock?

8 analysts have analysed DWTX and the average price target is 17.34 USD. This implies a price increase of 259.75% is expected in the next year compared to the current price of 4.82. Check the DOGWOOD THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DOGWOOD THERAPEUTICS INC worth?

DOGWOOD THERAPEUTICS INC (DWTX) has a market capitalization of 9.21M USD. This makes DWTX a Nano Cap stock.


How many employees does DOGWOOD THERAPEUTICS INC have?

DOGWOOD THERAPEUTICS INC (DWTX) currently has 12 employees.


What are the support and resistance levels for DOGWOOD THERAPEUTICS INC (DWTX) stock?

DOGWOOD THERAPEUTICS INC (DWTX) has a support level at 4.6 and a resistance level at 4.8. Check the full technical report for a detailed analysis of DWTX support and resistance levels.


Should I buy DOGWOOD THERAPEUTICS INC (DWTX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DOGWOOD THERAPEUTICS INC (DWTX) stock pay dividends?

DWTX does not pay a dividend.


When does DOGWOOD THERAPEUTICS INC (DWTX) report earnings?

DOGWOOD THERAPEUTICS INC (DWTX) will report earnings on 2025-08-06.


What is the Price/Earnings (PE) ratio of DOGWOOD THERAPEUTICS INC (DWTX)?

DOGWOOD THERAPEUTICS INC (DWTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.36).


What is the Short Interest ratio of DOGWOOD THERAPEUTICS INC (DWTX) stock?

The outstanding short interest for DOGWOOD THERAPEUTICS INC (DWTX) is 2.59% of its float. Check the ownership tab for more information on the DWTX short interest.


DWTX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to DWTX.


Chartmill TA Rating
Chartmill Setup Rating

DWTX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to DWTX. While DWTX has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DWTX Financial Highlights

Over the last trailing twelve months DWTX reported a non-GAAP Earnings per Share(EPS) of -13.36. The EPS decreased by -97.93% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -24.3%
ROE -28.4%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-139.43%
Sales Q2Q%N/A
EPS 1Y (TTM)-97.93%
Revenue 1Y (TTM)N/A

DWTX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to DWTX. The Buy consensus is the average rating of analysts ratings from 8 analysts.


Ownership
Inst Owners7.95%
Ins Owners2.01%
Short Float %2.59%
Short Ratio0.58
Analysts
Analysts82.5
Price Target17.34 (259.75%)
EPS Next Y10.49%
Revenue Next YearN/A